Neutrophils are significant producers of IL-10 during sepsis.

[1]  P. Kubes,et al.  Selective Down-Regulation of Neutrophil Mac-1 in Endotoxemic Hepatic Microcirculation via IL-101 , 2009, The Journal of Immunology.

[2]  Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation1 , 2009, The Journal of Immunology.

[3]  D. Herndon,et al.  Role of Polymorphonuclear Neutrophils on Infectious Complications Stemming from Enterococcus faecalis Oral Infection in Thermally Injured Mice1 , 2008, The Journal of Immunology.

[4]  T. Pritts,et al.  γδ T cells mitigate the organ injury and mortality of sepsis , 2008, Journal of leukocyte biology.

[5]  D. Rittirsch,et al.  The disconnect between animal models of sepsis and human sepsis , 2007, Journal of leukocyte biology.

[6]  Javed Siddiqui,et al.  Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality1 , 2006, The Journal of Immunology.

[7]  C. Elbim,et al.  Anti‐inflammatory effect of interleukin‐10 on human neutrophil respiratory burst involves inhibition of GM‐CSF‐induced p47PHOX phosphorylation through a decrease in ERK1/2 activity , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  I. Lee,et al.  THERMAL INJURY-INDUCED PRIMING EFFECT OF NEUTROPHIL IS TNF-&agr; AND P38 DEPENDENT , 2006, Shock.

[9]  M. Scott,et al.  Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection. , 2006, Cytokine.

[10]  J. Younger,et al.  HARMFUL AND PROTECTIVE ROLES OF NEUTROPHILS IN SEPSIS , 2005, Shock.

[11]  A. Levine,et al.  INTERLEUKIN 10 EXTENDS THE EFFECTIVENESS OF STANDARD THERAPY DURING LATE SEPSIS WITH SERUM INTERLEUKIN 6 LEVELS PREDICTING OUTCOME , 2005, Shock.

[12]  A. Ray,et al.  An important regulatory role for CD4+CD8αα T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Yan,et al.  Anti-IL-10 Therapeutic Strategy Using the Immunomodulator AS101 in Protecting Mice from Sepsis-Induced Death: Dependence on Timing of Immunomodulating Intervention1 , 2002, The Journal of Immunology.

[14]  M. Sitkovsky,et al.  Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions , 2001, The Journal of Immunology.

[15]  D. Dombrowicz,et al.  Human Eosinophils and Human High Affinity IgE Receptor Transgenic Mouse Eosinophils Express Low Levels of High Affinity IgE Receptor, but Release IL-10 upon Receptor Activation , 2001, The Journal of Immunology.

[16]  J. Granger,et al.  Immunopathologic responses to non-lethal sepsis. , 1999, Shock.

[17]  M. Feldmann,et al.  Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. , 1998, Journal of immunology.

[18]  P. Debré,et al.  Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3',5'-monophosphate-dependent mechanism. , 1997, Journal of immunology.

[19]  G. Trinchieri,et al.  Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. , 1997, Journal of immunology.

[20]  P. Huie,et al.  Interferon-gamma and interleukin-10 messenger RNA are up-regulated after orthotopic liver transplantation in tolerant rats: evidence for cytokine-mediated immune dysregulation. , 1995, Surgery.

[21]  J. F. Brown,et al.  Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. , 1994, Journal of immunology.

[22]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.